Navigation Links
Almost 1 quarter of Spanish women take antidepressants
Date:7/23/2009

Psychopharmaceutical use has risen over recent years. This is fact, but what is not clear is the reason why. Researchers from four Madrid-based health centres have shown that family conflict is not a significant factor. However, the results published in the journal Atencin Primaria are striking: in Spain, 24% of women take antidepressants and more than 30% take tranquillisers.

"The use of psychopharmaceuticals is often related to family or work-related problems. We wanted to see if there was actually a positive link between the consumption of antidepressants and benzodiazepines and any kind of family dysfunction", Sonsoles Prez, lead author of the study published in the renowned journal Atencin Primaria, and a doctor at the Las guilas Health Centre in Madrid, tells SINC.

The authors studied 121 women aged between 25 and 65, using family dysfunction surveys (the Apgar test), and the additive scale used to evaluate social readjustment (SLE). The psychopharmaceuticals analysed were antidepressants and benzodiazepines (anxiolytics such as lorazepam and bromazepam).

"Although one might think that family conflicts lead to greater consumption of psychopharmaceuticals among women, we did not find any such relationship", the researcher says, adding that the use of such drugs depends a lot on the population segment taking them. "Some people with family, work-related or financial problems do not feel able to tackle their problems and fall back on the use of drugs", Prez points out.

The results show that 24% of women in Spain use antidepressants and 30.6%, benzodiazepines, which are sometimes also used to help people sleep. In 78.6% of cases, these drugs are prescribed in primary health centres. The diagnosis is recorded in the patient's medical records in 64.5% of cases, with the primary causes being depression (11.6%), anxiety (9.9%) and insomnia (3.3%).

The scientists also found that benzodiazepine use increases with age. However, they did not find the same with antidepressant use. "We think that greater training is needed in identifying SLE and family dysfunction, and recording these in patients' records in order to help psychologists, psychiatrists and primary healthcare specialists", Prez concludes.

How is family conflict measured?

The relationship between the use of psychopharmaceuticals and family dysfunction has not been well studied. In order to gain a better understanding of family impacts on healthcare, and the effects of this illness on the family, the experts use numerical family functioning scales, such as the Apgar family test and the Stressful Life Events scale (SLE).

The first of these, developed in 1978 by Gabriel Smilkstein, allows measurements to be made of the functional health of a family using parameters such as adaptability (family resources for problem solving), participation (cooperation of family members), growth gradient (physical, emotional and social maturity on the basis of mutual support), affection (caring and loving relationships between members of the family group), and resolution (time-sharing and provision of resources to support all members of the family).

SLEs, events that the patient has suffered over the past year, act as triggers causing suffering and stress, and cause emotional problems in the individual and the family, such as the death of a partner, separation, imprisonment, being fired and unemployment. Each event is assigned a score based on its severity of between 100 (the most serious event), and 11 (the least serious). Patients are classified as high risk (with a score of 4,300), mid-risk (300-199), and low risk (less than 199).


'/>"/>

Contact: SINC
info@plataformasinc.es
34-914-251-820
FECYT - Spanish Foundation for Science and Technology
Source:Eurekalert  

Related medicine news :

1. Launch of Targeted Agents and Increased Use of Maintenance Therapy Will Drive the Non-Small-Cell Lung Cancer Drug Market to Nearly Triple to Almost $10 Billion in 2018
2. Supply of Key Childrens Vaccine Almost Back to Normal
3. McGill University receives almost $63 million under CFI program to support 5 research projects
4. Almost Half of Those Over 60 Die While Waiting for Kidney Transplant
5. Almost Quarter of Suicides Involve Intoxication
6. Almost Family to Present at Two Upcoming Conferences
7. New CASA* Report Finds Federal, State and Local Governments Spend Almost Half a Trillion Dollars a Year on Substance Abuse and Addiction
8. One in Five Americans Pee in Pool; Almost Half Admit Unhygienic Pool Behavior
9. Indias Non-Small-Cell Lung Cancer Drug Market Will Almost Double by 2013
10. Almost Family to Present at Two Upcoming Conferences
11. Almost Family Reports First Quarter 2009 Results
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Almost 1 quarter of Spanish women take antidepressants
(Date:3/27/2017)... ... March 27, 2017 , ... Mt. Angel Vitamins, a 5-year-old ... rebranding effort. This includes the introduction of new packaging and messaging, as well ... we learned that a simple, proactive approach to wellness is important to vitamin ...
(Date:3/27/2017)... RICHEY, Fla. (PRWEB) , ... March 27, 2017 ... ... drug overdose deaths soared 167%,(1) with opioids alone responsible for over 33,000 of ... Kevin McCarty has sponsored Assembly Bill (AB) 1512, which proposes a tax on ...
(Date:3/26/2017)... Ohio (PRWEB) , ... March 26, 2017 , ... ... doctors worldwide to receive the RealSelf 100 Award, a prestigious award honoring the ... cosmetic procedures and to find and connect with doctors and clinics. , In ...
(Date:3/24/2017)... ... 2017 , ... Clean Earth, Inc., a leader in providing ... materials announced today the acquisition of privately owned AERC Recycling Solutions ... facilities and a vast array of additional technologies, services, and new markets to ...
(Date:3/24/2017)... ... 24, 2017 , ... Infectious disease affects billions of people ... States, it’s a threat that is constantly changing and evolving. Mediaplanet's “Fighting Infection” ... strategies for the healthcare community to help decrease the number of completely preventable ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... -- Twist Bioscience, a company accelerating science and innovation through ... an additional $33 million. To date, Twist Bioscience has ... "It is an exciting time to be leading Twist ... deliver industry-leading gene volume to our customers, enabling innovative ... Ph.D., CEO of Twist Bioscience. "We welcome the additional ...
(Date:3/27/2017)... Texas , March 27, 2017   Genprex, Inc. , ... that Julien Pham , MD, the Company,s Chief Operating Officer, ... investor conferences. Sachs 5th Annual Cancer BioPartnering & ... New York, NY ... BioCentury 24th Annual Future Leaders in ...
(Date:3/24/2017)... PORTLAND, Oregon and PUNE, India , March 24, 2017 ... in 2015, and is estimated to reach $2,614 million by 2022, Globally, registering a ... expected to generate the highest revenue, and is projected to dominate the market during ... ... Allied Market Research Logo ...
Breaking Medicine Technology: